Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Accelerated Development and Manufacturing of Oral Small Molecules to be Discussed by Catalent Applied Drug Delivery Institute and JLABS | ||
By: PR Newswire Association LLC. - 30 Mar 2023 | Back to overview list |
|
The Catalent Applied Drug Delivery Institute, which was established as a cross-industry consortium to accelerate the adoption of advanced drug delivery technologies, today announced that it will hold a symposium in affiliation with Johnson & Johnson Innovation - JLABS (JLABS), entitled "The Road to IND: Accelerating Development & Manufacturing of Oral Small Molecules", on Tuesday, April 4, 2023, at JLABS @ San Diego. Experts and speakers from Catalent and JLABS will be joined by speakers from The Johnson & Johnson Family of Companies (Johnson & Johnson), UC San Diego, and Galileo Biosystems. SOMERSET, N.J., March 30, 2023 /PRNewswire-PRWeb/ -- The Catalent Applied Drug Delivery Institute, which was established as a cross-industry consortium to accelerate the adoption of advanced drug delivery technologies, today announced that it will hold a symposium in affiliation with Johnson & Johnson Innovation - JLABS (JLABS), entitled "The Road to IND: Accelerating Development & Manufacturing of Oral Small Molecules", on Tuesday, April 4, 2023, at JLABS @ San Diego. Experts and speakers from Catalent and JLABS will be joined by speakers from The Johnson & Johnson Family of Companies (Johnson & Johnson), UC San Diego, and Galileo Biosystems. This event will bring together delegates and speakers to network and share thoughts on innovations in the oral small molecule space. It will focus on decision making in the R&D environment when developing small molecule drug products, and ensuring time, resources and funding are used efficiently to address modern biopharmaceutical challenges, and accelerate programs to the clinic with the greatest potential of success. The events are the first of a series of events to be held in 2023 to mark the 10-year anniversary of the Catalent Applied Drug Delivery Institute, and coincides with the 90th anniversary of the softgel rotary die encapsulation technology invented by Robert Pauli Scherer (R.P. Scherer), which is the cornerstone of Catalent's innovative softgel-based oral dose delivery portfolio. Full details of the agenda and information on how to register for the event can be found here: https://www.eventbrite.com/e/road-to-indaccelerating-development-manufacturing-of-oral-small-molecule-tickets-537906150777?utm-campaign=social&utm-content=attendeeshare&utm-medium=discovery&utm-term=listing&utm-source=cp&aff=escb About Johnson & Johnson Innovation About the Catalent Applied Drug Delivery Institute About Catalent More products. Better treatments. Reliably supplied.™ Media Contact Chris Halling, Catalent, +447580041073, chris.halling@catalent.com Richard Kerns, Northern Exposure Public Relations, +441617285880, richard@nepr.agency
SOURCE Catalent |
||
|
||
Copyright 2023 PR Newswire Association LLC. | Back to overview list |